Niramai Health Analytix
A non-contact privacy-aware breast cancer screening solution that detects early stage breast abnormalities.
A non-contact privacy-aware breast cancer screening solution that detects early stage breast abnormalities.
Niramai Health Analytix is a health tech company founded in 2016 in India focused on saving lives by enabling the early detection of breast cancer in a privacy-aware manner. Their flagship solution, Thermalytix, is a non-contact breast health screening test utilizing proprietary machine learning and deep learning algorithms to analyze temperature distribution on the chest. This innovative approach automatically generates a quantitative report showing a breast health score, assisting doctors in identifying abnormal breast lesions. The company's last investment, a non-equity assistance investment, was made on 29 May 2024. As a leader in the health care industry, Niramai Health Analytix is addressing a critical need for early-stage breast cancer screenings with their novel, non-invasive approach.
This page is dedicated to updates regarding the latest developments about the industry and the company.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Non-equity Assistance | Unknown | - | 29 May 2024 | |
| Grant | Unknown | - | 29 Jun 2021 | |
| Grant | Unknown | - | 06 Oct 2020 | |
| Series A | Unknown | - | 25 Feb 2019 | |
| Non-equity Assistance | Unknown | - | 29 Nov 2017 |
No recent news or press coverage available for Niramai Health Analytix.
We care about your data, and we'd love to use cookies make your experience better.
